Innate Pharma to participate in the Evercore ISI 4th Annual Healthconx Virtual Conference
Innate Pharma Third Quarter 2021 Report
Innate Pharma highlights new NK cell engager data with partner Sanofi at SITC annual meeting
Innate Pharma announces Conference Call and Webcast for Q3 2021 Business Update
Innate Pharma 2022 Financial Calendar
Number of shares and voting rights of Innate Pharma as of October 1, 2021
Number of shares and voting rights of Innate Pharma as of September 1, 2021
Monalizumab data from COAST trial presented at ESMO Congress 2021
Innate Pharma Reports First Half 2021 Financial Results and Business Update
Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update
